M. Cantor

发表

Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease

Alexander E. Lopez, Eurie L. Hong, G. D. Gatta, 2022, Nature Genetics.

A catalog of associations between rare coding variants and COVID-19 outcomes

Alexander Hanbo Li, J. Marchini, G. Abecasis, 2020, medRxiv.

Genome-wide analysis in 756,646 individuals provides first genetic evidence 1 that ACE2 expression influences COVID-19 risk and yields genetic risk scores 2 predictive of severe disease 3

G. Sirugo, A. Girshick, L. Habegger, 2021 .

A first update on mapping the human genetic architecture of COVID-19

Eurie L. Hong, E. F. Perez, Rachel G Liao, 2022, Nature.

Common genetic variants identify targets for COVID-19 and individuals at 1 high risk of severe disease 2

G. Sirugo, A. Girshick, L. Habegger, 2021 .

Peer Review File Manuscript Title: Whole genome sequencing identifies multiple loci for critical illness caused by COVID-19 Reviewer Comments & Author Rebuttals

Mohammed A. Eid, Daniel J. Wilson, Nathan D. Berkowitz, 2022 .

Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis

L. Milani, B. Nordestgaard, K. Hveem, 2023, Critical care explorations.

NOTCH3 p.Arg1231Cys is Markedly Enriched in South Asians and Associated with Stroke

J. Danesh, D. Saleheen, F. Sepehrband, 2023, medRxiv.

ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma

Alexander E. Lopez, Tanya M. Teslovich, Gaurang C. Patel, 2022, Communications Biology.

Genotyping, sequencing and analysis of 140,000 adults from Mexico City

R. Collins, S. Balasubramanian, A. Hawes, 2023, Nature.

Whole-genome sequencing reveals host factors underlying critical COVID-19

Eurie L. Hong, Mohammed A. Eid, Daniel J. Wilson, 2022, Nature.

Genetic risk factors for COVID-19 and influenza are largely distinct.

Eurie L. Hong, A. Girshick, L. Habegger, 2024, Nature genetics.